TreeWAS – Variant ID: rs2183271

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
I10 Essential (primary) hypertension	1.000	0.000
Z88 Personal history of allergy to drugs, medicaments and biologocal substances	1.000	0.000
Z86 Personal history of certain other diseases	1.000	0.000
Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status	1.000	0.000
# Top node	1.000	0.000
I10-I15 Hypertensive diseases	1.000	0.000
Z86.0 Personal history of other neoplasms	1.000	0.000
Chapter X Diseases of the respiratory system	1.000	0.000
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances	0.999	0.001
Chapter IV Endocrine, nutritional and metabolic diseases	0.999	0.001
Chapter XXI Factors influencing health status and contact with health services	0.999	0.001
D32 Benign neoplasm of meninges	0.999	0.001
D32.0 Cerebral meninges	0.999	0.001
I12 Hypertensive renal disease	0.998	0.002
E20-E35 Disorders of other endocrine glands	0.998	0.002
Chapter II Neoplasms	0.998	0.002
J90-J94 Other diseases of pleura	0.998	0.002
D10-D36 Benign neoplasms	0.997	0.003
Z86.7 Personal history of diseases of the circulatory system	0.997	0.003
Z90 Acquired absence of organs, not elsewhere classified	0.996	0.004
Z90.2 Acquired absence of lung [part of]	0.996	0.004
I12.0 Hypertensive renal disease with renal failure	0.995	0.005
Z82 Family history of certain disabilities and chronic diseases leading to disablement	0.993	0.007
Z86.6 Personal history of diseases of the nervous system and sense organs	0.993	0.007
J91 Pleural effusion in conditions classified elsewhere	0.992	0.008
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.992	0.008
D35 Benign neoplasm of other and unspecified endocrine glands	0.992	0.008
Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system	0.992	0.008
Z98 Other postsurgical states	0.991	0.009
D35.1 Parathyroid gland	0.991	0.009
Z80 Family history of malignant neoplasm	0.987	0.013
Chapter VII Diseases of the eye and adnexa	0.986	0.014
D37-D48 Neoplasms of uncertain or unknown behaviour	0.981	0.019
H10-H13 Disorders of conjunctiva	0.981	0.019
Z98.8 Other specified postsurgical states	0.979	0.021
H11 Other disorders of conjunctiva	0.977	0.023
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.976	0.024
Chapter V Mental and behavioural disorders	0.975	0.025
E21.3 Hyperparathyroidism, unspecified	0.974	0.026
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.972	0.028
F40-F48 Neurotic, stress-related and somatoform disorders	0.970	0.030
J92 Pleural plaque	0.970	0.030
D00-D09 In situ neoplasms	0.967	0.033
D32.9 Meninges, unspecified	0.967	0.033
J95-J99 Other diseases of the respiratory system	0.967	0.033
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.963	0.037
Z88.2 Personal history of allergy to sulphonamides	0.960	0.040
J60-J70 Lung diseases due to external agents	0.960	0.040
Z88.7 Personal history of allergy to serum and vaccine	0.960	0.040
E65-E68 Obesity and other hyperalimentation	0.959	0.041
F41 Other anxiety disorders	0.958	0.042
I15 Secondary hypertension	0.956	0.044
Z98.1 Arthrodesis status	0.954	0.046
D37.4 Colon	0.954	0.046
Z80.3 Family history of malignant neoplasm of breast	0.953	0.047
J00-J06 Acute upper respiratory infections	0.953	0.047
Z86.4 Personal history of psychoactive substance abuse	0.951	0.049
Chapter IX Diseases of the circulatory system	0.949	0.051
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.948	0.052
Z88.5 Personal history of allergy to narcotic agent	0.948	0.052
E50-E64 Other nutritional deficiencies	0.947	0.053
E28 Ovarian dysfunction	0.945	0.055
J98 Other respiratory disorders	0.945	0.055
H18 Other disorders of cornea	0.942	0.058
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.940	0.060
E23 Hypofunction and other disorders of pituitary gland	0.935	0.065
D37.1 Stomach	0.931	0.069
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.930	0.070
D04 Carcinoma in situ of skin	0.930	0.070
J98.1 Pulmonary collapse	0.928	0.072
E66 Obesity	0.923	0.077
Z90.3 Acquired absence of part of stomach	0.920	0.080
D04.3 Skin of other and unspecified parts of face	0.919	0.081
D05 Carcinoma in situ of breast	0.914	0.086
J06 Acute upper respiratory infections of multiple and unspecified sites	0.913	0.087
H11.0 Pterygium	0.912	0.088
I12.9 Hypertensive renal disease without renal failure	0.909	0.091
D29 Benign neoplasm of male genital organs	0.909	0.091
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.908	0.092
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.907	0.093
D05.9 Carcinoma in situ of breast, unspecified	0.906	0.094
Z82.5 Family history of asthma and other chronic lower respiratory diseases	0.905	0.095
Z90.7 Acquired absence of genital organ(s)	0.904	0.096
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.902	0.098
J92.0 Pleural plaque with presence of asbestos	0.900	0.100
Z88.1 Personal history of allergy to other antibiotic agents	0.897	0.103
H11.8 Other specified disorders of conjunctiva	0.896	0.104
J92.9 Pleural plaque without asbestos	0.891	0.109
I15.1 Hypertension secondary to other renal disorders	0.891	0.109
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.889	0.111
F70-F79 Mental retardation	0.889	0.111
J06.9 Acute upper respiratory infection, unspecified	0.884	0.116
J04 Acute laryngitis and tracheitis	0.880	0.120
Z80.8 Family history of malignant neoplasm of other organs or systems	0.880	0.120
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.878	0.122
F40 Phobic anxiety disorders	0.876	0.124
H46-H48 Disorders of optic nerve and visual pathways	0.874	0.126
D29.1 Prostate	0.874	0.126
C43-C44 Melanoma and other malignant neoplasms of skin	0.874	0.126
E23.0 Hypopituitarism	0.872	0.128
E28.2 Polycystic ovarian syndrome	0.866	0.134
E61 Deficiency of other nutrient elements	0.865	0.135
Z57 Occupational exposure to risk-factors	0.862	0.138
D12.4 Descending colon	0.862	0.138
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.861	0.139
E66.8 Other obesity	0.857	0.143
H11.4 Other conjunctival vascular disorders and cysts	0.853	0.147
H11.1 Conjunctival degenerations and deposits	0.851	0.149
H18.2 Other corneal oedema	0.850	0.150
J40-J47 Chronic lower respiratory diseases	0.848	0.152
C43 Malignant melanoma of skin	0.848	0.152
C43.7 Malignant melanoma of lower limb, including hip	0.848	0.152
C49 Malignant neoplasm of other connective and soft tissue	0.848	0.152
D37.3 Appendix	0.845	0.155
Z70-Z76 Persons encountering health services in other circumstances	0.845	0.155
H11.9 Disorder of conjunctiva, unspecified	0.844	0.156
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.843	0.157
E66.9 Obesity, unspecified	0.843	0.157
Chapter XXII Codes for special purposes	0.842	0.157
J45 Asthma	0.840	0.160
H21 Other disorders of iris and ciliary body	0.839	0.161
F44 Dissociative [conversion] disorders	0.839	0.161
D24 Benign neoplasm of breast	0.834	0.166
J98.9 Respiratory disorder, unspecified	0.833	0.167
E23.7 Disorder of pituitary gland, unspecified	0.828	0.172
F79 Unspecified mental retardation	0.828	0.172
J45.9 Asthma, unspecified	0.828	0.172
E61.1 Iron deficiency	0.825	0.175
F41.9 Anxiety disorder, unspecified	0.823	0.177
F41.8 Other specified anxiety disorders	0.823	0.177
J95 Postprocedural respiratory disorders, not elsewhere classified	0.822	0.178
D31 Benign neoplasm of eye and adnexa	0.822	0.178
H17 Corneal scars and opacities	0.821	0.179
Z88.3 Personal history of allergy to other anti-infective agents	0.820	0.180
F42 Obsessive-compulsive disorder	0.820	0.180
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs	0.819	0.181
E28.3 Primary ovarian failure	0.817	0.183
Z88.0 Personal history of allergy to penicillin	0.815	0.185
E53 Deficiency of other B group vitamins	0.814	0.186
Z97 Presence of other devices	0.814	0.186
Z57.2 Occupational exposure to dust	0.813	0.187
E34 Other endocrine disorders	0.813	0.187
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.813	0.187
D37.9 Digestive organ, unspecified	0.812	0.188
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.812	0.188
H18.9 Disorder of cornea, unspecified	0.811	0.189
J98.8 Other specified respiratory disorders	0.807	0.193
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.804	0.196
H47 Other disorders of optic [2nd] nerve and visual pathways	0.802	0.198
D12.6 Colon, unspecified	0.801	0.199
I15.8 Other secondary hypertension	0.801	0.199
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.795	0.205
D32.1 Spinal meninges	0.794	0.205
J04.0 Acute laryngitis	0.791	0.209
D27 Benign neoplasm of ovary	0.789	0.211
E21.2 Other hyperparathyroidism	0.788	0.212
H18.8 Other specified disorders of cornea	0.787	0.213
Z75 Problems related to medical facilities and other health care	0.787	0.213
F79.9 Unspecified mental retardation (Without mention of impairment of behaviour)	0.784	0.216
H22.1 Iridocyclitis in other diseases classified elsewhere	0.782	0.218
E40-E46 Malnutrition	0.781	0.219
Z72 Problems related to lifestyle	0.780	0.220
D01 Carcinoma in situ of other and unspecified digestive organs	0.779	0.221
Z72.0 Tobacco use	0.779	0.221
D30 Benign neoplasm of urinary organs	0.779	0.221
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.779	0.221
F52 Sexual dysfunction, not caused by organic disorder or disease	0.777	0.223
E21.5 Disorder of parathyroid gland, unspecified	0.770	0.230
J93 Pneumothorax	0.769	0.231
H13 Disorders of conjunctiva in diseases classified elsewhere	0.769	0.231
H40-H42 Glaucoma	0.769	0.231
E31 Polyglandular dysfunction	0.768	0.232
E32 Diseases of thymus	0.768	0.232
D26 Other benign neoplasms of uterus	0.767	0.232
D12.8 Rectum	0.767	0.233
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.766	0.234
Z82.6 Family history of arthritis and other diseases of the musculoskeletal system and connective tissue	0.764	0.236
I11 Hypertensive heart disease	0.764	0.236
I13 Hypertensive heart and renal disease	0.763	0.237
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.762	0.238
F51 Nonorganic sleep disorders	0.762	0.238
H11.2 Conjunctival scars	0.761	0.239
C50-C50 Malignant neoplasm of breast	0.759	0.241
D04.0 Skin of lip	0.758	0.242
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.757	0.243
D04.4 Skin of scalp and neck	0.757	0.243
H18.5 Hereditary corneal dystrophies	0.755	0.245
E63 Other nutritional deficiencies	0.754	0.246
E20 Hypoparathyroidism	0.752	0.248
H18.0 Corneal pigmentations and deposits	0.751	0.249
H18.6 Keratoconus	0.751	0.249
C64-C68 Malignant neoplasms of urinary tract	0.749	0.251
Z99.2 Dependence on renal dialysis	0.748	0.252
F41.3 Other mixed anxiety disorders	0.748	0.252
F40.8 Other phobic anxiety disorders	0.747	0.253
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.747	0.253
Z75.1 Person awaiting admission to adequate facility elsewhere	0.746	0.254
E53.8 Deficiency of other specified B group vitamins	0.746	0.254
C43.5 Malignant melanoma of trunk	0.745	0.255
Z58 Problems related to physical environment	0.744	0.256
Z97.4 Presence of external hearing-aid	0.744	0.256
F44.5 Dissociative convulsions	0.740	0.260
J94 Other pleural conditions	0.736	0.264
J04.1 Acute tracheitis	0.735	0.265
J62 Pneumoconiosis due to dust containing silica	0.734	0.266
H17.9 Corneal scar and opacity, unspecified	0.734	0.266
C49.0 Connective and soft tissue of head, face and neck	0.734	0.266
E65 Localised adiposity	0.733	0.267
Z80.5 Family history of malignant neoplasm of urinary tract	0.732	0.268
J45.0 Predominantly allergic asthma	0.732	0.268
E26 Hyperaldosteronism	0.731	0.268
J42 Unspecified chronic bronchitis	0.730	0.270
J95.9 Postprocedural respiratory disorder, unspecified	0.730	0.270
H47.1 Papilloedema, unspecified	0.728	0.272
D02 Carcinoma in situ of middle ear and respiratory system	0.728	0.272
Z99.8 Dependence on other enabling machines and devices	0.728	0.272
C49.5 Connective and soft tissue of pelvis	0.727	0.273
Z63 Other problems related to primary support group, including family circumstances	0.726	0.274
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.724	0.276
Z57.5 Occupational exposure to toxic agents in other industries	0.723	0.277
D33 Benign neoplasm of brain and other parts of central nervous system	0.723	0.277
H18.1 Bullous keratopathy	0.723	0.277
I15.9 Seconday hypertension, unspecified	0.722	0.277
E56 Other vitamin deficiencies	0.721	0.279
J93.9 Pneumothorax, unspecified	0.721	0.279
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.720	0.280
D37.7 Other digestive organs	0.718	0.282
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
F40.2 Specific (isolated) phobias	0.717	0.283
D06 Carcinoma in situ of cervix uteri	0.716	0.284
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.716	0.284
E35 Disorders of endocrine glands in diseases classified elsewhere	0.716	0.284
E30 Disorders of puberty, not elsewhere classified	0.716	0.284
E25 Adrenogenital disorders	0.716	0.284
D37.2 Small intestine	0.715	0.285
C49.9 Connective and soft tissue, unspecified	0.715	0.285
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.715	0.285
D19 Benign neoplasm of mesothelial tissue	0.715	0.285
J98.5 Diseases of mediastinum, not elsewhere classified	0.715	0.285
D44.7 Aortic body and other paraganglia	0.715	0.285
D26.1 Corpus uteri	0.714	0.286
Z82.8 Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified	0.712	0.288
E29 Testicular dysfunction	0.712	0.288
H15 Disorders of sclera	0.712	0.288
D35.9 Endocrine gland, unspecified	0.711	0.289
D35.8 Pluriglandular involvement	0.711	0.289
D35.7 Other specified endocrine glands	0.711	0.289
D35.6 Aortic body and other paraganglia	0.711	0.289
D35.5 Carotid body	0.711	0.289
D35.4 Pineal gland	0.711	0.289
D35.3 Craniopharyngeal duct	0.711	0.289
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.704	0.296
D45 Polycythaemia vera	0.704	0.296
J70 Respiratory conditions due to other external agents	0.703	0.297
D37.0 Lip, oral cavity and pharynx	0.703	0.297
I26 Pulmonary embolism	0.702	0.298
H21.9 Disorder of iris and ciliary body, unspecified	0.700	0.300
Z74 Problems related to care-provider dependency	0.698	0.302
I15.0 Renovascular hypertension	0.697	0.303
Z60 Problems related to social environment	0.696	0.304
J64 Unspecified pneumoconiosis	0.696	0.304
E51 Thiamine deficiency	0.696	0.304
J96 Respiratory failure, not elsewhere classified	0.693	0.307
D48.1 Connective and other soft tissue	0.693	0.307
Z81 Family history of mental and behavioural disorders	0.692	0.307
H21.2 Degeneration of iris and ciliary body	0.692	0.308
E21.4 Other specified disorders of parathyroid gland	0.691	0.309
E21.0 Primary hyperparathyroidism	0.691	0.309
D38.1 Trachea, bronchus and lung	0.689	0.311
I00-I02 Acute rheumatic fever	0.688	0.312
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.688	0.312
J66 Airway disease due to specific organic dust	0.688	0.312
J63 Pneumoconiosis due to other inorganic dusts	0.688	0.312
J65 Pneumoconiosis associated with tuberculosis	0.688	0.312
C49.3 Connective and soft tissue of thorax	0.687	0.313
E67 Other hyperalimentation	0.687	0.313
E68 Sequelae of hyperalimentation	0.687	0.313
H47.3 Other disorders of optic disk	0.687	0.313
J60 Coalworker's pneumoconiosis	0.685	0.315
J98.2 Interstitial emphysema	0.685	0.315
I15.2 Hypertension secondary to endocrine disorders	0.684	0.316
J46 Status asthmaticus	0.684	0.316
D04.1 Skin of eyelid, including canthus	0.684	0.316
D44.1 Adrenal gland	0.682	0.318
D31.0 Conjunctiva	0.681	0.319
Z63.7 Other stressful life events affecting family and household	0.681	0.319
C65 Malignant neoplasm of renal pelvis	0.679	0.321
E64 Sequelae of malnutrition and other nutritional deficiencies	0.679	0.321
E50 Vitamin A deficiency	0.679	0.321
E60 Dietary zinc deficiency	0.679	0.321
E59 Dietary selenium deficiency	0.679	0.321
E52 Niacin deficiency [pellagra]	0.679	0.321
E28.9 Ovarian dysfunction, unspecified	0.678	0.322
E28.8 Other ovarian dysfunction	0.678	0.322
E28.1 Androgen excess	0.678	0.322
E28.0 Oestrogen excess	0.678	0.322
J98.3 Compensatory emphysema	0.677	0.322
E54 Ascorbic acid deficiency	0.677	0.322
F50 Eating disorders	0.677	0.323
H18.7 Other corneal deformities	0.675	0.325
Z57.3 Occupational exposure to other air contaminants	0.674	0.325
E66.2 Extreme obesity with alveolar hypoventilation	0.674	0.326
E22 Hyperfunction of pituitary gland	0.674	0.326
C40-C41 Malignant neoplasms of bone and articular cartilage	0.672	0.328
F42.0 Predominantly obsessional thoughts or ruminations	0.672	0.328
D12.7 Rectosigmoid junction	0.671	0.329
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.671	0.329
E23.1 Drug-induced hypopituitarism	0.671	0.329
D30.3 Bladder	0.670	0.330
F42.2 Mixed obsessional thoughts and acts	0.669	0.331
F52.2 Failure of genital response	0.668	0.332
D04.6 Skin of upper limb, including shoulder	0.668	0.332
F40.1 Social phobias	0.668	0.332
D29.4 Scrotum	0.667	0.333
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.667	0.333
J00 Acute nasopharyngitis [common cold]	0.667	0.333
D04.8 Skin of other sites	0.667	0.333
H21.4 Pupillary membranes	0.666	0.333
D17 Benign lipomatous neoplasm	0.667	0.333
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.666	0.334
D44.4 Craniopharyngeal duct	0.662	0.338
E66.1 Drug-induced obesity	0.662	0.338
Z80.6 Family history of leukaemia	0.662	0.338
I11.9 Hypertensive heart disease without (congestive) heart failure	0.661	0.339
D12.5 Sigmoid colon	0.659	0.341
F51.5 Nightmares	0.659	0.341
D01.0 Colon	0.658	0.342
J98.0 Diseases of bronchus, not elsewhere classified	0.657	0.343
H21.1 Other vascular disorders of iris and ciliary body	0.657	0.343
F55 Abuse of non-dependence-producing substances	0.656	0.344
J06.8 Other acute upper respiratory infections of multiple sites	0.654	0.345
J06.0 Acute laryngopharyngitis	0.654	0.345
D55-D59 Haemolytic anaemias	0.654	0.346
C49.4 Connective and soft tissue of abdomen	0.654	0.346
Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.654	0.346
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.653	0.347
F40.0 Agoraphobia	0.652	0.348
D12.9 Anus and anal canal	0.652	0.348
D29.9 Male genital organ, unspecified	0.651	0.348
D29.7 Other male genital organs	0.651	0.348
D29.3 Epididymis	0.651	0.348
E34.3 Short stature, not elsewhere classified	0.651	0.349
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.651	0.349
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.651	0.349
Z62 Other problems related to upbringing	0.651	0.349
Z55 Problems related to education and literacy	0.651	0.349
Z61 Problems related to negative life events in childhood	0.650	0.350
Z75.5 Holiday relief care	0.650	0.350
Z82.2 Family history of deafness and hearing loss	0.647	0.352
J45.8 Mixed asthma	0.647	0.352
U80 Agent resistant to penicillin and related antibiotics	0.647	0.353
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.647	0.353
H13.3 Ocular pemphigoid	0.647	0.353
D46 Myelodysplastic syndromes	0.647	0.353
F41.2 Mixed anxiety and depressive disorder	0.646	0.354
C37 Malignant neoplasm of thymus	0.645	0.355
D48.0 Bone and articular cartilage	0.645	0.355
H10 Conjunctivitis	0.643	0.357
H53-H54 Visual disturbances and blindness	0.641	0.359
C68 Malignant neoplasm of other and unspecified urinary organs	0.640	0.360
Z80.7 Family history of malignant neoplasms of lymphoid, haematopoietic and related tissues	0.639	0.361
I28 Other diseases of pulmonary vessels	0.639	0.361
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.638	0.362
F78 Other mental retardation	0.638	0.362
F73 Profound mental retardation	0.638	0.362
F72 Severe mental retardation	0.638	0.362
F71 Moderate mental retardation	0.638	0.362
F70 Mild mental retardation	0.638	0.362
F80-F89 Disorders of psychological development	0.637	0.362
D80-D89 Certain disorders involving the immune mechanism	0.635	0.365
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.634	0.366
F44.4 Dissociative motor disorders	0.634	0.366
J04.2 Acute laryngotracheitis	0.631	0.369
D35.0 Adrenal gland	0.631	0.369
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.630	0.370
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.630	0.370
C46 Kaposi's sarcoma	0.630	0.370
F43 Reaction to severe stress, and adjustment disorders	0.629	0.371
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.629	0.371
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.627	0.373
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.627	0.373
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.627	0.373
Z99.0 Dependence on aspirator	0.626	0.374
H18.3 Changes in corneal membranes	0.626	0.374
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.626	0.374
Z94 Transplanted organ and tissue status	0.625	0.375
Z97.0 Presence of artificial eye	0.625	0.375
E46 Unspecified protein-energy malnutrition	0.625	0.375
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.625	0.375
D05.7 Other carcinoma in situ of breast	0.625	0.375
F44.8 Other dissociative [conversion] disorders	0.624	0.376
Z90.6 Acquired absence of other parts of urinary tract	0.622	0.378
D12.0 Caecum	0.621	0.379
E34.9 Endocrine disorder, unspecified	0.621	0.379
H21.8 Other specified disorders of iris and ciliary body	0.621	0.379
D33.2 Brain, unspecified	0.620	0.380
E61.9 Deficiency of nutrient element, unspecified	0.620	0.380
E61.8 Deficiency of other specified nutrient elements	0.620	0.380
E61.7 Deficiency of multiple nutrient elements	0.620	0.380
E61.6 Vanadium deficiency	0.620	0.380
E61.5 Molybdenum deficiency	0.620	0.380
E61.4 Chromium deficiency	0.620	0.380
E61.3 Manganese deficiency	0.620	0.380
E61.0 Copper deficiency	0.620	0.380
Z57.9 Occupational exposure to unspecified risk-factor	0.618	0.382
Z57.7 Occupational exposure to vibration	0.618	0.382
Z57.6 Occupational exposure to extreme temperature	0.618	0.382
Z57.4 Occupational exposure to toxic agents in agriculture	0.618	0.382
Z57.1 Occupational exposure to radiation	0.618	0.382
Z57.0 Occupational exposure to noise	0.618	0.382
E23.2 Diabetes insipidus	0.618	0.382
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.618	0.382
C49.1 Connective and soft tissue of upper limb, including shoulder	0.618	0.382
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.617	0.383
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.617	0.383
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.617	0.383
E34.0 Carcinoid syndrome	0.617	0.383
D44.9 Endocrine gland, unspecified	0.616	0.384
E63.9 Nutritional deficiency, unspecified	0.615	0.385
D31.3 Choroid	0.613	0.387
H40 Glaucoma	0.613	0.387
D38.0 Larynx	0.613	0.387
Z60.9 Problem related to social environment, unspecified	0.612	0.388
H16 Keratitis	0.611	0.388
U81 Agent resistant to vancomycin and related antibiotics	0.611	0.388
D11 Benign neoplasm of major salivary glands	0.611	0.389
Z58.7 Exposure to tobacco smoke	0.609	0.391
D50-D53 Nutritional anaemias	0.609	0.391
D29.2 Testis	0.608	0.392
C43.8 Overlapping malignant melanoma of skin	0.608	0.392
C43.0 Malignant melanoma of lip	0.608	0.392
Z70 Counselling related to sexual attitude, behaviour and orientation	0.608	0.392
E58 Dietary calcium deficiency	0.608	0.392
C49.8 Overlapping lesion of connective and soft tissue	0.608	0.392
C49.6 Connective and soft tissue of trunk, unspecified	0.608	0.392
Z65 Problems related to other psychosocial circumstances	0.608	0.392
F40.9 Phobic anxiety disorder, unspecified	0.607	0.393
U51 Admission status on psychiatric patients	0.607	0.393
H47.2 Optic atrophy	0.605	0.395
D44.5 Pineal gland	0.605	0.395
D44.2 Parathyroid gland	0.605	0.395
D04.9 Skin, unspecified	0.603	0.396
E31.0 Autoimmune polyglandular failure	0.603	0.397
E32.8 Other diseases of thymus	0.602	0.398
H21.3 Cyst of iris, ciliary body and anterior chamber	0.602	0.398
F44.7 Mixed dissociative [conversion] disorders	0.601	0.398
F44.6 Dissociative anaesthesia and sensory loss	0.601	0.398
F44.3 Trance and possession disorders	0.601	0.398
F44.2 Dissociative stupor	0.601	0.398
F44.1 Dissociative fugue	0.601	0.398
F44.0 Dissociative amnesia	0.601	0.398
Z97.1 Presence of artificial limb (complete)(partial)	0.601	0.399
D48.2 Peripheral nerves and autonomic nervous system	0.600	0.400
E16 Other disorders of pancreatic internal secretion	0.599	0.401
D44.8 Pluriglandular involvement	0.599	0.401
E55 Vitamin D deficiency	0.599	0.401
H46 Optic neuritis	0.597	0.403
Z91 Personal history of risk-factors, not elsewhere classified	0.596	0.404
J94.2 Haemothorax	0.595	0.405
Z64 Problems related to certain psychosocial circumstances	0.594	0.405
Z82.1 Family history of blindness and visual loss	0.594	0.406
Z90.4 Acquired absence of other parts of digestive tract	0.594	0.406
F79.8 Unspecified mental retardation (Other impairments of behaviour)	0.594	0.406
F79.1 Unspecified mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.594	0.406
F79.0 Unspecified mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.594	0.406
D09 Carcinoma in situ of other and unspecified sites	0.593	0.407
I13.9 Hypertensive heart and renal disease, unspecified	0.593	0.407
C43.1 Malignant melanoma of eyelid, including canthus	0.593	0.407
D86 Sarcoidosis	0.593	0.407
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.591	0.408
J95.5 Postprocedural subglottic stenosis	0.590	0.410
J95.4 Mendelson's syndrome	0.590	0.410
J95.3 Chronic pulmonary insufficiency following surgery	0.590	0.410
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.590	0.410
D31.9 Eye, unspecified	0.589	0.411
D31.6 Orbit, unspecified	0.589	0.411
D31.5 Lachrymal gland and duct	0.589	0.411
D31.4 Ciliary body	0.589	0.411
D31.2 Retina	0.589	0.411
D31.1 Cornea	0.589	0.411
E20.1 Pseudohypoparathyroidism	0.589	0.411
H17.1 Other central corneal opacity	0.589	0.411
H17.0 Adherent leukoma	0.589	0.411
E66.0 Obesity due to excess calories	0.588	0.412
D13.2 Duodenum	0.588	0.412
F42.8 Other obsessive-compulsive disorders	0.588	0.412
F42.1 Predominantly compulsive acts [obsessional rituals]	0.588	0.412
C50.9 Breast, unspecified	0.587	0.413
C50 Malignant neoplasm of breast	0.587	0.413
Z98.2 Presence of cerebrospinal fluid drainage device	0.587	0.413
J95.8 Other postprocedural respiratory disorders	0.586	0.414
D30.4 Urethra	0.585	0.415
F52.0 Lack or loss of sexual desire	0.585	0.415
E53.1 Pyridoxine deficiency	0.584	0.416
E53.0 Riboflavin deficiency	0.584	0.416
J02 Acute pharyngitis	0.584	0.416
E34.5 Androgen resistance syndrome	0.583	0.417
E34.4 Constitutional tall stature	0.583	0.417
E34.2 Ectopic hormone secretion, not elsewhere classified	0.583	0.417
E34.1 Other hypersecretion of intestinal hormones	0.583	0.417

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations